BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson PL, Shekhar A. An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus. Physiol Behav 2012;107:686-98. [PMID: 22484112 DOI: 10.1016/j.physbeh.2012.03.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Ullah F, dos Anjos-garcia T, dos Santos IR, Biagioni AF, Coimbra NC. Relevance of dorsomedial hypothalamus, dorsomedial division of the ventromedial hypothalamus and the dorsal periaqueductal gray matter in the organization of freezing or oriented and non-oriented escape emotional behaviors. Behavioural Brain Research 2015;293:143-52. [DOI: 10.1016/j.bbr.2015.07.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
2 Winter A, Ahlbrand R, Sah R. Recruitment of central angiotensin II type 1 receptor associated neurocircuits in carbon dioxide associated fear. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;92:378-86. [DOI: 10.1016/j.pnpbp.2019.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Bevins RA, Besheer J. Interoception and learning: import to understanding and treating diseases and psychopathologies. ACS Chem Neurosci 2014;5:624-31. [PMID: 25010473 DOI: 10.1021/cn5001028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
4 Lovick TA. Sex determinants of experimental panic attacks. Neuroscience & Biobehavioral Reviews 2014;46:465-71. [DOI: 10.1016/j.neubiorev.2014.03.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
5 Caldirola D, Alciati A, Riva A, Perna G. Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years. Expert Opin Pharmacother 2018;19:1357-68. [PMID: 30063164 DOI: 10.1080/14656566.2018.1504921] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Sonmez AI, Almorsy A, Ramsey LB, Strawn JR, Croarkin PE. Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations. Depress Anxiety 2020;37:747-59. [PMID: 32419335 DOI: 10.1002/da.23038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Biagioni AF, de Freitas RL, da Silva JA, de Oliveira RC, de Oliveira R, Alves VM, Coimbra NC. Serotonergic neural links from the dorsal raphe nucleus modulate defensive behaviours organised by the dorsomedial hypothalamus and the elaboration of fear-induced antinociception via locus coeruleus pathways. Neuropharmacology 2013;67:379-94. [PMID: 23201351 DOI: 10.1016/j.neuropharm.2012.10.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
8 Nascimento JO, Kikuchi LS, de Bortoli VC, Zangrossi H, Viana MB. Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze. Brain Research Bulletin 2014;109:39-45. [DOI: 10.1016/j.brainresbull.2014.09.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kirouac GJ. The Paraventricular Nucleus of the Thalamus as an Integrating and Relay Node in the Brain Anxiety Network. Front Behav Neurosci 2021;15:627633. [PMID: 33732118 DOI: 10.3389/fnbeh.2021.627633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
10 Viana TG, Bastos JR, Costa RB, Hott SC, Mansur FS, Coimbra CC, Resstel LB, Aguiar DC, Moreira FA. Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks. Neuropharmacology 2019;148:284-90. [DOI: 10.1016/j.neuropharm.2019.01.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Hassell J, Yamashita P, Johnson P, Zangrossi H, Shekhar A, Lowry C. Stress, Panic, and Central Serotonergic Inhibition. Stress: Neuroendocrinology and Neurobiology. Elsevier; 2017. pp. 153-64. [DOI: 10.1016/b978-0-12-802175-0.00015-2] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Bondarenko E, Beig MI, Hodgson DM, Braga VA, Nalivaiko E. Blockade of the dorsomedial hypothalamus and the perifornical area inhibits respiratory responses to arousing and stressful stimuli. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2015;308:R816-22. [DOI: 10.1152/ajpregu.00415.2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
13 Hoffman KL. Modeling disorders of fear and anxiety in animals. Modeling Neuropsychiatric Disorders in Laboratory Animals. Elsevier; 2016. pp. 87-160. [DOI: 10.1016/b978-0-08-100099-1.00003-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Sant’ana AB, Vilela-costa HH, Vicente MA, Hernandes PM, de Andrade TGCS, Zangrossi H. Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats. Neuropharmacology 2019;148:311-9. [DOI: 10.1016/j.neuropharm.2019.01.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Fernandes GG, Frias AT, Spiacci A, Pinheiro LC, Tanus-santos JE, Zangrossi H. Nitric oxide in the dorsal periaqueductal gray mediates the panic-like escape response evoked by exposure to hypoxia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;92:321-7. [DOI: 10.1016/j.pnpbp.2019.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Wang W, Schuette PJ, Nagai J, Tobias BC, Cuccovia V Reis FM, Ji S, de Lima MAX, La-Vu MQ, Maesta-Pereira S, Chakerian M, Leonard SJ, Lin L, Severino AL, Cahill CM, Canteras NS, Khakh BS, Kao JC, Adhikari A. Coordination of escape and spatial navigation circuits orchestrates versatile flight from threats. Neuron 2021;109:1848-1860.e8. [PMID: 33861942 DOI: 10.1016/j.neuron.2021.03.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Vilela-costa HH, Spiacci A, Bissolli IG, Zangrossi H. A Shift in the Activation of Serotonergic and Non-serotonergic Neurons in the Dorsal Raphe Lateral Wings Subnucleus Underlies the Panicolytic-Like Effect of Fluoxetine in Rats. Mol Neurobiol 2019;56:6487-500. [DOI: 10.1007/s12035-019-1536-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Park SC, Kim YK. A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder. Psychiatry Investig 2019;16:4-15. [PMID: 30301303 DOI: 10.30773/pi.2018.08.21.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Roncon CM, Yamashita PSDM, Frias AT, Audi EA, Graeff FG, Coimbra NC, Zangrossi H. μ-Opioid and 5-HT1A receptors in the dorsomedial hypothalamus interact for the regulation of panic-related defensive responses. J Psychopharmacol 2017;31:715-21. [DOI: 10.1177/0269881117693747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
20 Luchetti A, Oddi D, Lampis V, Centofante E, Felsani A, Battaglia M, D'Amato FR. Early handling and repeated cross-fostering have opposite effect on mouse emotionality. Front Behav Neurosci 2015;9:93. [PMID: 25954170 DOI: 10.3389/fnbeh.2015.00093] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
21 Hassell JE, Nguyen KT, Gates CA, Lowry CA. The Impact of Stressor Exposure and Glucocorticoids on Anxiety and Fear. In: Coolen LM, Grattan DR, editors. Neuroendocrine Regulation of Behavior. Cham: Springer International Publishing; 2019. pp. 271-321. [DOI: 10.1007/7854_2018_63] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
22 Johnson PL, Federici LM, Shekhar A. Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neurosci Biobehav Rev 2014;46 Pt 3:429-54. [PMID: 25130976 DOI: 10.1016/j.neubiorev.2014.07.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
23 Molosh AI, Dustrude ET, Lukkes JL, Fitz SD, Caliman IF, Abreu ARR, Dietrich AD, Truitt WA, Ver Donck L, Ceusters M, Kent JM, Johnson PL, Shekhar A. Panic results in unique molecular and network changes in the amygdala that facilitate fear responses. Mol Psychiatry 2020;25:442-60. [PMID: 30108314 DOI: 10.1038/s41380-018-0119-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Bonaventure P, Dugovic C, Shireman B, Preville C, Yun S, Lord B, Nepomuceno D, Wennerholm M, Lovenberg T, Carruthers N, Fitz SD, Shekhar A, Johnson PL. Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation. Front Pharmacol 2017;8:357. [PMID: 28649201 DOI: 10.3389/fphar.2017.00357] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
25 Johnson PL, Federici LM, Fitz SD, Renger JJ, Shireman B, Winrow CJ, Bonaventure P, Shekhar A. OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES. Depress Anxiety 2015;32:671-83. [PMID: 26332431 DOI: 10.1002/da.22403] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
26 Flores Á, Saravia R, Maldonado R, Berrendero F. Orexins and fear: implications for the treatment of anxiety disorders. Trends in Neurosciences 2015;38:550-9. [DOI: 10.1016/j.tins.2015.06.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
27 Solanki RR, Scholl JL, Watt MJ, Renner KJ, Forster GL. Amphetamine Withdrawal Differentially Increases the Expression of Organic Cation Transporter 3 and Serotonin Transporter in Limbic Brain Regions. J Exp Neurosci 2016;10:93-100. [PMID: 27478387 DOI: 10.4137/JEN.S40231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Raitiere MN. Does photoperiodism involve a seasonal and non-pathological Warburg effect? Medical Hypotheses 2020;135:109447. [DOI: 10.1016/j.mehy.2019.109447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Goncharuk VD, Buijs RM, Jhamandas JH, Swaab DF. The hypothalamic neuropeptide FF network is impaired in hypertensive patients. Brain Behav 2014;4:453-67. [PMID: 25161813 DOI: 10.1002/brb3.229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Abreu AR, Molosh AI, Johnson PL, Shekhar A. Role of medial hypothalamic orexin system in panic, phobia and hypertension. Brain Res 2020;1731:145942. [PMID: 30205108 DOI: 10.1016/j.brainres.2018.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
31 Moreira FA, Gobira PH, Viana TG, Vicente MA, Zangrossi H, Graeff FG. Modeling panic disorder in rodents. Cell Tissue Res 2013;354:119-25. [DOI: 10.1007/s00441-013-1610-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
32 Takeuchi Y, Berényi A. Oscillotherapeutics - Time-targeted interventions in epilepsy and beyond. Neurosci Res 2020;152:87-107. [PMID: 31954733 DOI: 10.1016/j.neures.2020.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
33 Perna G, Schruers K, Alciati A, Caldirola D. Novel investigational therapeutics for panic disorder. Expert Opinion on Investigational Drugs 2015;24:491-505. [DOI: 10.1517/13543784.2014.996286] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
34 de Bortoli VC, Yamashita PSDM, Zangrossi H. 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus. J Psychopharmacol 2013;27:1116-23. [DOI: 10.1177/0269881113492900] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
35 O'Farrell K, Harkin A. Stress-related regulation of the kynurenine pathway: Relevance to neuropsychiatric and degenerative disorders. Neuropharmacology 2017;112:307-23. [PMID: 26690895 DOI: 10.1016/j.neuropharm.2015.12.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
36 Vollmer LL, Strawn JR, Sah R. Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational update. Transl Psychiatry 2015;5:e572. [PMID: 26080089 DOI: 10.1038/tp.2015.67] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
37 Caldirola D, Alciati A, Cuniberti F, Perna G. Experimental Drugs for Panic Disorder: An Updated Systematic Review. J Exp Pharmacol 2021;13:441-59. [PMID: 33889031 DOI: 10.2147/JEP.S261403] [Reference Citation Analysis]
38 Bonaventure P, Yun S, Johnson PL, Shekhar A, Fitz SD, Shireman BT, Lebold TP, Nepomuceno D, Lord B, Wennerholm M, Shelton J, Carruthers N, Lovenberg T, Dugovic C. A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effects. J Pharmacol Exp Ther 2015;352:590-601. [PMID: 25583879 DOI: 10.1124/jpet.114.220392] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]